Table 2.
Type of thrombotic event and antithrombotic therapy at the time of event
| Type of TE | Total n (%) |
On VKA n (%) |
On LMWH n (%) |
On LDA n (%) |
No AC n (%) |
|---|---|---|---|---|---|
| All TE | 32 (100.0%) | 14 (45.2%) | 4 (12.9%) | 7 (22.6%) | 8 (25.8%) |
| Venous TE | 16 (50.0%) | 8 (53.3%) | 3 (20.0%) | 3 (20.0%) | 3 (20.0%) |
| Lower extremity DVT | 6 (18.8%) | 4 (66.7%) | 0 (0.0%) | 0 (0.0%) | 2 (33.3%) |
| Isolated PE | 6 (18.8%) | 2 (40.0%) | 1 (20.0%) | 2 (40.0%) | 1 (20.0%) |
| Lower extremity DVT + PE | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Upper extremity DVT | 1 (3.1%) | 0 (0.0%) | 1 (100.0%) | 1 (100.0%) | 0 (0.0%) |
| Renal vein thrombosis | 1 (3.1%) | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) |
| Ocular vein thrombosis | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Arterial TE | 16 (50.0%) | 6 (37.5%) | 1 (6.3%) | 4 (25.0%) | 5 (31.3%) |
| Stroke | 8 (25.0%) | 3 (37.5%) | 0 (0.0%) | 1 (12.5%) | 3 (37.5%) |
| TIA | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) |
| Myocardial infarction | 5 (15.6%) | 1 (20.0%) | 1 (20.0%) | 1 (20.0%) | 2 (40.0%) |
| Peripheral artery TE | 2 (6.3%) | 1 (50.0%) | 0 (0.0%) | 1 (50.0%) | 0 (0.0%) |
TE thrombotic events, DVT deep vein thrombosis, PE pulmonary embolism, VKA vitamin K antagonist, LMWH low molecular weight heparin, LDA low dose aspirin, AC anticoagulation